Avigan maker to seek virus treatment approval after trials show shortened recovery time
Of 156 individuals described as "analysis targets," the median recovery time was 11.9 days in those receiving Avigan compared with 14.7 for patients given a placebo.
Fujifilm completes delayed Avigan clinical test and looks to government application
Fujifilm Holdings Corp. said Monday it has completed delayed clinical tests of Avigan, a potential treatment for COVID-19, paving the way for the application of sales and production of the antivirus drug. Fujifilm Toyama Chemical Co., a subsidiary of Fujifilm Holdings, is conducting analysis of ...
Philippines begins nine-month clinical trial on Avigan in COVID-19 study
The Philippines started nine-month clinical trials for Avigan on Monday to study the efficacy of the Japanese anti-flu drug against the disease caused by the new coronavirus. Health Undersecretary Maria Rosario Vergeire said the clinical trials will include just four hospitals in Metro Manila initially ...
Fujifilm to complete delayed Avigan clinical trials in Japan in September
Fujifilm Holdings Corp. said Thursday it expects to complete clinical tests in Japan of the antiviral drug Avigan, a potential candidate treatment drug for COVID-19, in September, already behind schedule after a delay caused by difficulty in securing enough patient data. The last patient will ...
Fujifilm to start another Avigan study in Kuwait following setback in Japan
The trial is to be conducted with India's Dr. Reddy's Laboratories and will involve up to 1,000 people to assess the flu drug's effectiveness against the coronavirus.
Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.
Fujifilm ties up with Indian firm on potential COVID-19 drug Avigan
The drug has yet to be approved by the Japanese government for coronavirus treatment, with clinical testing delayed due to insufficient enrollment.
Wanted: More COVID-19 patients in Japan ... for clinical trials
Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in trials for treatments and vaccines.
Fujifilm's COVID-19 drug research will drag on into July, source says
The recent fall in the number of confirmed infections has made it difficult to reach the enrollment target of 96 patients.
After fast-tracking Japanese COVID-19 drug, Russia to roll out 'game changer' next week
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as "a game changer" that should speed a return to normal economic life. Russian hospitals can begin giving the drug ...
Japan extends timeline for approving Fujifilm's Avigan drug for COVID-19
Fujifilm shares slumped last week after it was reported that an interim study showed no clear evidence of efficacy for Avigan in COVID-19 cases.
Fujifilm plans to make flu drug Avigan available for 2 million people by March 2021
Fujifilm Holdings Corp. said Friday it is on course to supply the flu drug Avigan for 2 million COVID-19 patients by next March, meeting a target set by the government to ramp up production of the potential but yet unapproved coronavirus treatment. "We plan to ...
